Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Phosphine/diimine ruthenium complexes with Cl-, CO, NO+, NO2-, NO3- and pyridine ligands: Pro-apoptotic activity on triple-negative breast cancer cells and DNA/HSA interactions

Texto completo
Autor(es):
Reis Silva, Henrique Vieira [1] ; Moreira Dias, Julia Scaff [1] ; Ferreira-Silva, Guilherme Alvaro [2] ; Vegas, Legna Colina [3] ; Ionta, Marisa [2] ; Correa, Charlane Cimini [4] ; Batista, Alzir Azevedo [3] ; Frazao Barbosa, Marilia Imaculada [1] ; Doriguetto, Antonio Carlos [1]
Número total de Autores: 9
Afiliação do(s) autor(es):
[1] Univ Fed Alfenas, Inst Quim, BR-37130001 Alfenas, MG - Brazil
[2] Univ Fed Alfenas, Inst Ciencias Biomed, BR-37130001 Alfenas, MG - Brazil
[3] Univ Fed Sao Carlos, Dept Quim, CP 676, BR-13565905 Sao Carlos, SP - Brazil
[4] Univ Fed Juiz de Fora, Dept Quim, BR-36036900 Juiz De Fora, MG - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: Polyhedron; v. 144, p. 55-65, APR 1 2018.
Citações Web of Science: 5
Resumo

A series of five new ruthenium phosphine/diimine complexes were prepared and characterized by IR, UV-Vis, H-1, P-31[H-1] and C-13[H-1] NMR spectroscopies, elemental analyses and cyclic voltammetry. Four of the complexes have the general formula ct-{[}RuCl(L)(dppb)(4,4'-Mebipy)](PF6)(n) (dppb = 1,4-bis (diphenylphosphino)butane, 4,4'-Mebipy = 4,4'-dimethyl-2,2-bipyridine and L = CO, NO+, NO2- or pyridine), and one has the formula {[}Ru(NO3)(dppb)(4,4'-Mebipy)]PF6, where NO3- is a bidentate ligand. In addition, the crystal structure of the complex ct-{[}RuCl(CO)(dppb)(4,4'-Mebipy)]PF6 was elucidated by single-crystal X-ray diffraction analysis, which supported the geometry of the compounds suggested by the P-31 NMR experiments. The cytotoxic activity of the synthesized compounds was evaluated against five cancer cell lines: HepG2 (liver), HT144 (melanoma), A549 (lung), MDA-MB-231 (breast) and HCT-9 (colon). Human serum albumin (HSA) and DNA binding experiments were also conducted. The HSA binding constants and thermodynamic parameters suggested spontaneous interactions of the complexes with this protein through van der Waals forces and hydrogen bonding. A spectroscopic titration study indicated that the compounds interacted with ct-DNA, exhibiting binding constants, K-b, on the order of 1.0 x 10(4) M-1. Additionally, the ruthenium complex containing pyridine displayed cytotoxic activity against HT144, A549, and MDA-MB-231. In addition, it demonstrated pro-apoptotic activity on MDA-MB-231 cells as well as the ability to reduce colony formation. These findings are very promising and have motivated further studies for identifying the molecular target underlying the antitumor activity of the ruthenium(II)/pyridine complex against triple-negative breast cancer. (C) 2018 Elsevier Ltd. All rights reserved. (AU)

Processo FAPESP: 16/23130-5 - Determinação da biodistribuição celular de Cu, Ru e Pt em células humanas tumorais e não tumorais de mama mediante a técnica de espectrometria de massas com plasma acoplado indutivamente
Beneficiário:Legna Andreina Colina Vegas
Linha de fomento: Bolsas no Brasil - Pós-Doutorado